Processa Pharmaceuticals, Inc.

NasdaqCM:PCSA Rapporto sulle azioni

Cap. di mercato: US$3.7m

Processa Pharmaceuticals Gestione

Gestione criteri di controllo 3/4

Processa Pharmaceuticals' CEO is George Ng, appointed in Aug 2023, has a tenure of 1.25 years. total yearly compensation is $714.03K, comprised of 22.3% salary and 77.7% bonuses, including company stock and options. directly owns 0.61% of the company’s shares, worth $23.00K. The average tenure of the management team and the board of directors is 4.2 years and 4.7 years respectively.

Informazioni chiave

George Ng

Amministratore delegato

US$714.0k

Compenso totale

Percentuale dello stipendio del CEO22.3%
Mandato del CEO1.3yrs
Proprietà del CEO0.6%
Durata media del management4.2yrs
Durata media del Consiglio di amministrazione4.7yrs

Aggiornamenti recenti sulla gestione

Recent updates

We Think Processa Pharmaceuticals (NASDAQ:PCSA) Needs To Drive Business Growth Carefully

Dec 12
We Think Processa Pharmaceuticals (NASDAQ:PCSA) Needs To Drive Business Growth Carefully

Will Processa Pharmaceuticals (NASDAQ:PCSA) Spend Its Cash Wisely?

Oct 20
Will Processa Pharmaceuticals (NASDAQ:PCSA) Spend Its Cash Wisely?

Processa Pharmaceuticals GAAP EPS of $0.53 beats by $0.73

Aug 12

We Think Processa Pharmaceuticals (NASDAQ:PCSA) Needs To Drive Business Growth Carefully

Jul 07
We Think Processa Pharmaceuticals (NASDAQ:PCSA) Needs To Drive Business Growth Carefully

We're Not Very Worried About Processa Pharmaceuticals' (NASDAQ:PCSA) Cash Burn Rate

Jan 20
We're Not Very Worried About Processa Pharmaceuticals' (NASDAQ:PCSA) Cash Burn Rate

Processa Pharmaceuticals (NASDAQ:PCSA) Is In A Good Position To Deliver On Growth Plans

Aug 26
Processa Pharmaceuticals (NASDAQ:PCSA) Is In A Good Position To Deliver On Growth Plans

Processa Pharmaceuticals (PCSA) Presents At LD Micro Invitations XI Virtual Conference - Slideshow

Jun 15

What Percentage Of Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) Shares Do Insiders Own?

Mar 15
What Percentage Of Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) Shares Do Insiders Own?

Processa Pharmaceuticals: Multiple Shots On Goal With Total TAM Of $8B - Worth A Look

Jan 29

How Many Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) Shares Did Insiders Buy, In The Last Year?

Jan 20
How Many Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) Shares Did Insiders Buy, In The Last Year?

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di George Ng rispetto agli utili di Processa Pharmaceuticals?
DataCompenso totaleStipendioGuadagni aziendali
Sep 30 2024n/an/a

-US$12m

Jun 30 2024n/an/a

-US$10m

Mar 31 2024n/an/a

-US$10m

Dec 31 2023US$714kUS$159k

-US$11m

Compensazione vs Mercato: George's total compensation ($USD714.03K) is about average for companies of similar size in the US market ($USD655.65K).

Compensazione vs guadagni: Insufficient data to compare George's compensation with company performance.


AMMINISTRATORE DELEGATO

George Ng (50 yo)

1.3yrs

Mandato

US$714,031

Compensazione

Mr. George K. Ng, Esq. JD serves as CEO of Processa Pharmaceuticals, Inc. since August 08, 2023 and serves as its Director since August 08, 2023 and served as its Director since August 08 2023 until 2024....


Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
George Ng
CEO & Director1.3yrsUS$714.03k0.61%
$ 23.0k
David Young
Co-Founder7.8yrsUS$186.64k2.82%
$ 105.4k
Sian Bigora
Co-Founder and Chief Development & Regulatory Officerno dataUS$321.73k0.67%
$ 25.2k
Patrick Lin
Co-Founder7.8yrsUS$1.04m0.89%
$ 33.4k
Wendy Guy
Co-Founder7.1yrsUS$1.02m0.36%
$ 13.6k
Russell Skibsted
Chief Financial Officerless than a yearNessun datoNessun dato
Steven Cha
Senior Vice President of Clinical Researchless than a yearNessun datoNessun dato

4.2yrs

Durata media

62yo

Età media

Gestione esperta: PCSA's management team is considered experienced (4.2 years average tenure).


Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
George Ng
CEO & Director1.3yrsUS$714.03k0.61%
$ 23.0k
David Young
Co-Founder7.1yrsUS$186.64k2.82%
$ 105.4k
James Neal
Independent Director2.3yrsUS$83.00k0.022%
$ 829.3
John Devane
Member of Medical & Scientific Advisory Board4.7yrsNessun datoNessun dato
Justin Yorke
Independent Chairman of Board7.3yrsUS$54.00k0.11%
$ 4.3k
James Shipley
Member of Medical & Scientific Advisory Board4.7yrsNessun datoNessun dato
Stuart Madden
Member of Medical & Scientific Advisory Board2.1yrsNessun datoNessun dato
Khoso Baluch
Independent Director2.3yrsUS$83.00k0.043%
$ 1.6k
Geraldine Pannu
Independent Director4.8yrsUS$54.00k0.088%
$ 3.3k

4.7yrs

Durata media

61.5yo

Età media

Consiglio di amministrazione esperto: PCSA's board of directors are considered experienced (4.7 years average tenure).